Follow
Michael Birrer
Michael Birrer
Professor Medicine HMS
Verified email at partners.org
Title
Cited by
Cited by
Year
Integrated genomic analyses of ovarian carcinoma
Cancer Genome Atlas Research Network
Nature 474 (7353), 609, 2011
60002011
Integrated genomic characterization of endometrial carcinoma
DA Levine
Nature 497 (7447), 67-73, 2013
35532013
The immune landscape of cancer
V Thorsson, DL Gibbs, SD Brown, D Wolf, DS Bortone, THO Yang, ...
Immunity 48 (4), 812-830. e14, 2018
26902018
Incorporation of bevacizumab in the primary treatment of ovarian cancer
RA Burger, MF Brady, MA Bookman, GF Fleming, BJ Monk, H Huang, ...
New England Journal of Medicine 365 (26), 2473-2483, 2011
23812011
Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis
M Verheij, R Bose, X Hua Lin, B Yao, WD Jarvis, S Grant, MJ Birrer, ...
Nature 380 (6569), 75-79, 1996
22101996
Comprehensive characterization of cancer driver genes and mutations
MH Bailey, C Tokheim, E Porta-Pardo, S Sengupta, D Bertrand, ...
Cell 173 (2), 371-385. e18, 2018
15972018
Oncogenic signaling pathways in the cancer genome atlas
F Sanchez-Vega, M Mina, J Armenia, WK Chatila, A Luna, KC La, ...
Cell 173 (2), 321-337. e10, 2018
15952018
An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics
J Liu, T Lichtenberg, KA Hoadley, LM Poisson, AJ Lazar, AD Cherniack, ...
Cell 173 (2), 400-416. e11, 2018
15552018
p53: a frequent target for genetic abnormalities in lung cancer
T Takahashi, MM Nau, I Chiba, MJ Birrer, RK Rosenberg, M Vinocour, ...
Science 246 (4929), 491-494, 1989
15321989
Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer
KA Hoadley, C Yau, T Hinoue, DM Wolf, AJ Lazar, E Drill, R Shen, ...
Cell 173 (2), 291-304. e6, 2018
13852018
Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial
RL Coleman, AM Oza, D Lorusso, C Aghajanian, A Oaknin, A Dean, ...
The Lancet 390 (10106), 1949-1961, 2017
11622017
BRCA mutation frequency and patterns of treatment response in BRCA mutation–positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group
K Alsop, S Fereday, C Meldrum, A DeFazio, C Emmanuel, J George, ...
Journal of Clinical Oncology 30 (21), 2654, 2012
11612012
Oncogenic and transcriptional cooperation with Ha-Ras requires phosphorylation of c-Jun on serines 63 and 73
T Smeal, B Binetruy, DA Mercola, M Birrer, M Karin
Nature 354 (6353), 494-496, 1991
9691991
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
DD Bowtell, S Böhm, AA Ahmed, PJ Aspuria, RC Bast, V Beral, JS Berek, ...
Nature reviews Cancer 15 (11), 668-679, 2015
9242015
Machine learning identifies stemness features associated with oncogenic dedifferentiation
TM Malta, A Sokolov, AJ Gentles, T Burzykowski, L Poisson, JN Weinstein, ...
Cell 173 (2), 338-354. e15, 2018
8482018
Dicer, Drosha, and outcomes in patients with ovarian cancer
WM Merritt, YG Lin, LY Han, AA Kamat, WA Spannuth, R Schmandt, ...
New England Journal of Medicine 359 (25), 2641-2650, 2008
8232008
Integrated genomic and molecular characterization of cervical cancer
Cancer Genome Atlas Research Network
Nature 543 (7645), 378, 2017
7782017
Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer
L Zhang, S Volinia, T Bonome, GA Calin, J Greshock, N Yang, CG Liu, ...
Proceedings of the National Academy of Sciences 105 (19), 7004-7009, 2008
6692008
Inherited mutations in women with ovarian carcinoma
BM Norquist, MI Harrell, MF Brady, T Walsh, MK Lee, S Gulsuner, ...
JAMA oncology 2 (4), 482-490, 2016
6052016
Genomic and molecular landscape of DNA damage repair deficiency across The Cancer Genome Atlas
TA Knijnenburg, L Wang, MT Zimmermann, N Chambwe, GF Gao, ...
Cell reports 23 (1), 239-254. e6, 2018
5902018
The system can't perform the operation now. Try again later.
Articles 1–20